Syndax Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Syndax Pharmaceuticals, Inc.

May-08	Syndax Announces Participation in May Investor Conferences SNDX GlobeNewswire
May-07	Syndax Announces Publication of Pivotal Revumenib Data in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia in the Journal Blood SNDX GlobeNewswire
May-05	Syndax Reports First Quarter 2025 Financial Results and Provides Business Update SNDX GlobeNewswire
May-02	Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) SNDX GlobeNewswire